Content area

|
|

Recidiv af venøs tromboemboli

Forfatter(e)
Jørn Dalsgaard Nielsen1, Erik Lerkevang Grove2, 3, Torben Bjerregaard Larsen4 & Anette Arbjerg Højen4 1) Videncenter for Antikoagulant Behandling,
Hjerteafdelingen, Bispebjerg og Frederiksberg Hospitaler2) Hjertesygdomme, Aarhus
Universitetshospital3) Institut for Klinisk Medicin,
Aarhus Universitet4) Aalborg Thrombosis Research Unit, Kardiologisk Afdeling, Aalborg
Universitetshospital

Ugeskr Læger 2018;180:V03180177
Reference: 
Ugeskr Læger 2018;180:V03180177
Blad nummer: 
Sidetal: 

Jørn Dalsgaard Nielsen, Erik Lerkevang Grove,
Torben Bjerregaard Larsen & Anette Arbjerg Højen:

Recurrence of venous thromboembolism

Ugeskr Læger 2018;180:V03180177

Recurrence of venous thromboembolism (VTE) is seen in approximately one third of the patients after discontinuation of therapy with anticoagulants. The duration of treatment seems to be of minor importance, as several studies have shown the same recurrence rate over years after treatment for three months and up to 24 months. In patients with reversible risk factors, three months of treatment seems to be sufficient. Treatment duration should be determined by physicians with special expertise in risk factors for VTE recurrence and bleeding complications.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Anne Gersdorff Korsgaard | 20/10
1 Kommentar
af Karen Brink Linnet | 19/10
1 Kommentar
af Thor Andersen Knudsen | 19/10
2 kommentarer
af Ole Lindgård Dollerup | 18/10
1 Kommentar
af Kristine Rasmussen | 18/10
1 Kommentar
af Camilla Bang | 16/10
1 Kommentar
af Tobias Ramm Eberlein | 15/10
6 kommentarer
af Frank Bang Nissen | 15/10
1 Kommentar